Alembic Pharma gets USFDA nod for Fluphenazine Hydrochloride Tablets Ruchika Sharma24 July 2024 3:29 PM ISTVadodara: Alembic Pharmaceuticals Limited today announced that the Company has received final approval from the US Food & Drug...
Gradual Antipsychotic Dose Reduction May Increase Relapse risk in Psychotic Disorders Dr Riya Dave9 Oct 2023 10:00 AM ISTA recent study led by Dr. Joanna Moncrieff from University College London suggests that reducing or discontinuing antipsychotic medication in patients...
Schizophrenia may significantly increase risk of dementia Dr. Kamal Kant Kohli12 Oct 2022 10:00 AM ISTPeople with psychotic disorders such as schizophrenia are 2.5 times more likely than those without a psychotic disorder to eventually develop...
Medical treatment of pediatric psychiatric disorders reduces later onset of substance use problems Dr. Kamal Kant Kohli25 May 2022 9:30 AM ISTBOSTON: One half of psychiatric and substance use disorders start by the age of 18; three-quarters by age 24. While these are concerning statistics, a...
'No gifts' to doctors from pharma companies, hints the govt Pooja Bhatia Bhatia12 Oct 2015 11:06 AM ISTIn a step to make it mandatory for the pharma companies to follow a uniform marketing code, the govt is all set to issue a directive of 'no gifts' to...
